Global Biotech Stocks

FunPep

Market Cap: JP¥4.3b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

FLUENT

Market Cap: US$28.7m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

Advicenne

Market Cap: €24.5m

A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.

Sat Kartar Shopping

Market Cap: ₹2.5b

An ayurvedic healthcare company, provides ayurvedic products in India.

Human Metabolome Technologies

Market Cap: JP¥4.2b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Microbix Biosystems

Market Cap: CA$39.1m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Ribomic

Market Cap: JP¥4.2b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

Kezar Life Sciences

Market Cap: US$27.8m

A clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.

BioLASCO Taiwan

Market Cap: NT$847.8m

Provides bio-materials and surgical services in Taiwan and internationally.

Vitura Health

Market Cap: AU$42.4m

Engages in the sale and distribution of medicinal cannabis products in Australia.

Beit Jala Pharmaceutical

Market Cap: د.أ19.6m

Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.

IRLAB Therapeutics

Market Cap: SEK 256.9m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.

Seach Medical Group

Market Cap: ₪90.9m

Manufactures and sells medicinal cannabis products worldwide.

Syntara

Market Cap: AU$40.8m

Operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia.

GeneBioTech Ltd

Market Cap: ₩36.3b

Engages in the manufacture and sale of feed additives and functional food in South Korea.

Karolinska Development

Market Cap: SEK 242.8m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Seoul Pharma

Market Cap: ₩36.2b

Manufactures and sells pharmaceutical products in South Korea and internationally.

Boundless Bio

Market Cap: US$25.6m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).

Zelluna

Market Cap: NOK 256.2m

Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.

MFC

Market Cap: ₩35.7b

Operates as a pharmaceutical company in South Korea.

Enlivex Therapeutics

Market Cap: US$24.9m

Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.

Propanc Biopharma

Market Cap: US$24.8m

A development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.

Passage Bio

Market Cap: US$24.5m

A genetic medicines company, develops gene therapies for central nervous system diseases.

Transgenic Group

Market Cap: JP¥3.7b

Develops, distributes, and licenses genetically modified animals and antibodies in Japan.

Kontafarma China Holdings

Market Cap: HK$190.0m

An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.

ChoA Pharmaceutical

Market Cap: ₩34.1b

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea.

Simply Solventless Concentrates

Market Cap: CA$33.5m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Little Green Pharma

Market Cap: AU$36.7m

Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.

China Health Group

Market Cap: HK$184.1m

An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.

Bilcare

Market Cap: ₹2.1b

Provides pharmaceutical packaging research solutions in India and internationally.

Bioray Biotech

Market Cap: NT$710.0m

Engages in the research and development, manufacture, and sale of biological and health supplement products.

PuraPharm

Market Cap: HK$177.8m

An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.

Respiratorius

Market Cap: €19.4m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

SAB Biotherapeutics

Market Cap: US$22.5m

A clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders.

Alpa Laboratories

Market Cap: ₹2.0b

Engages in the manufacture and sale of drugs and chemicals in India.

Neuphoria Therapeutics

Market Cap: US$21.5m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.